<DOC>
	<DOCNO>NCT01273350</DOCNO>
	<brief_summary>Prospective , non-randomized , single-center cohort study treat internal carotid artery stenosis use Xact Carotid Artery Stent emboshield distal protection system conjunction bivalirudin procedural anticoagulation</brief_summary>
	<brief_title>A Prospective , Non-Randomized , Evaluation Low-Risk Patients Undergoing Carotid Stenting With ANgiomax ( Bivalirudin )</brief_title>
	<detailed_description>Primary objective evaluate safety feasibility XACT stent emboshield Angiomax procedural anticoagulant . Primary safety endpoint occurrence Major Adverse Events , define death , myocardial infarction ( Q non Q wave ) , target revascularization one year</detailed_description>
	<mesh_term>Carotid Stenosis</mesh_term>
	<mesh_term>Bivalirudin</mesh_term>
	<criteria>Patient ( male nonpregnant female ) must &gt; or= 18 Qualifying noninvasive test ( ultrasound MRA ) perform less 60 day prior study entry . Carotid duplex study reveal : Stenosis &gt; = 50 % symptomatic patient Stenosis &gt; = 60 % asymptomatic patient Target lesion may common internal carotid artery amenable treatment angioplasty stenting Patients take warfarin may include dosage reduce procedure result INR 1.5 less Prothrombin time 15 second . Warfarin may start procedure . Female patient childbearing potential must document negative pregnancy test index hospitalization Patient legally authorize representative must sign write informed consent , prior procedure , use form approve local institutional review board medical ethic committee ( Patients exclude study ANY follow condition present ) There total occlusion target carotid artery treatment site . The patient allergy contraindication aspirin , ticlopidine , clopidogrel , bivalirudin , nickel , titanium , sensitivity contrast medium , adequately premedicated . The subject platlet count &lt; 100,000 cells/mm3 700,000 cells/mm3 WBC &lt; 3,000 cells/mm3 . Stroke within 7 day prior procedure NIH stroke score &gt; = 15 within 7 day prior procedure The patient experience significant GI bleed within 6 month prior study procedure The patient active internal bleed The patient major surgery serious trauma within 6 week enrollment The patient excessive peripheral vascular disease precludes safe sheath insertion The patient intracranial hemorrhage , hemorrhagic stroke , major stroke stroke within one week index procedure The patient concurrent emboligenic cardiovascular disease adequately treat anticoagulant therapy The patient renal dialysis The patient low molecular weight heparin ( LMWH ) administer within 8 hour less , prior procedure Severe hypertension adequately control antihypertensive therapy time study entry ( BP &gt; 180/110mmHG ) The patient unable unwilling cooperate study followup procedure</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2014</verification_date>
	<keyword>internal carotid artery</keyword>
	<keyword>common carotid artery</keyword>
	<keyword>bruit</keyword>
	<keyword>tia</keyword>
</DOC>